Health Care/Hospital

Clarity's theranostic prostate cancer trial advances to cohort 2

Highlights * Cohort 1 of the SECuRE trial has been completed in 6 participants with metastatic castrate-resistant prostate cancer (mCRPC) who received therapy with 67Cu SAR-bisPSMA at the lowest dose level of 4GBq. * No dose limiting toxicities (DLTs) have been reported in cohort 1. * The Sa...

2023-05-24 21:03 2499

Avixgen accelerates the progress on new drug pipeline development

- Pipeline development updates on age related macular degeneration, dry eye disease and atopic dermatitis SEOUL, South Korea, May 24, 2023 /PRNewswire/ -- DxVx has released development updates on the pipelines of its recently acquired company, Avixgen. DxVx acquired about 63% stake of Avixgen, w...

2023-05-24 21:00 2622

Ping An Asset Management: China's Aging Society Sparks Pension Interest, Becomes the Next Opportunity for Asset Management Industry

HONG KONG and SHANGHAI, May 24, 2023 /PRNewswire/ -- China is with great potential and very open for high standard players, saysJacqueline Zhang, Deputy General Manager of Ping An Asset Management Co., Ltd. ("Ping An AMC"), during a panel at the Future of Asset Management Asia event, hosted by th...

2023-05-24 17:36 3798

BioRay Filed IND Application for BRY812, a Novel Antibody Drug Conjugate Targeting LIV-1

SHANGHAI, May 24, 2023 /PRNewswire/ -- BioRay Pharmaceutical Co., Ltd. (hereinafter referred to as BioRay) announced that the Investigational New Drug (IND) application for the clinical trial of its proprietary BRY812,a novel antibody-drug conjugate (ADC) targeting human LIV-1 for the treatment o...

2023-05-24 16:14 1797

HKBN x Mannings Pioneer FREE Pharmacist Consultations for Talents

PharmaCare Pilot Programme allows HKBN Talents to enjoy HK's leading flexible benefit package HONG KONG, May 24, 2023 /PRNewswire/ -- As flu season and COVID-19 continues, long queues are common at doctor's clinics. As a Talent-obsessed company,HKBN Group ("HKBN"), and Hong Kong's largest health...

2023-05-24 14:56 2190

Singapore University of Social Sciences leapfrogs innovation and entrepreneurship in gerontology for Singapore and Asia

Inaugural SUSS Geronpreneurship Innovation Festival at World Ageing Festival and multiple initiatives to boost age inclusivity and eldercare SINGAPORE, May 24, 2023 /PRNewswire/ -- Singapore University of Social Sciences (SUSS) has launched the inaugural Geronpreneurship Innovation Festival and ...

2023-05-24 14:32 2169

Improved Overall Health, Better Sleep, and Enhanced Immunity Ranked as Top Three Health Goals by Increasingly Health-Conscious Asia Pacific Consumers - Herbalife Survey

The survey reveals 84% of Asia Pacific Consumers recognize the importance of a support group in helping them achieve health and wellness goals HONG KONG, May 24, 2023 /PRNewswire/ -- Herbalife, a premier health and wellness company and community, today released the findings of its Asia Pacific H...

2023-05-24 12:31 2666

Allgenesis Announces Encouraging Preliminary Safety and Efficacy Data from the AG-73305 Phase 2a Trial for the Treatment of Diabetic Macular Edema

* AG-73305 was found to be safe and tolerable with no severe adverse effects (SAEs) after a single intravitreal injection of 0.5 mg and 1 mg in DME patients. * AG-73305 showed median improvements in Best Corrected Visual Accuity (BCVA) of 8.5 ETDRS letters with median Central Subfield Thickness...

2023-05-24 10:24 1755

Chula Researchers Discover "Highly Effective Antibodies against COVID-19," Leading to "COVITRAP Nasal Spray" to Curb Infection at the Start

BANGKOK, May 24, 2023 /PRNewswire/ -- A research team at the Center of Excellence in Systems Biology, Faculty of Medicine,Chulalongkorn University, has identified "highly effective antibodies against COVID-19" from the human body. These antibodies have been developed into an innovation called "C...

2023-05-24 10:00 2489

Infinitus Meets 520 Social Responsibility Day Goal for 5 Years, Promoting Healthy Living

GUANGZHOU, China, May 24, 2023 /PRNewswire/ -- On May 20, Infinitus hosted the 520 Infinitus Social Responsibility Day for the 5th consecutive year at Infinitus Plaza inGuangzhou, centered around this year's theme, "You and I Together for a Healthy Lifestyle". The event, broadcasted live online, ...

2023-05-24 08:00 2194

ESOC 2023: AI tool outperforms human emergency call handlers in identifying stroke, new study shows

MUNICH, May 24, 2023 /PRNewswire/ -- Researchers from Denmark have developed a new artificial intelligence (AI) framework to address the number of strokes that go unrecognised by human emergency call handlers. The framework outperformed emergency call handlers in recognising stroke for both sexes...

2023-05-24 06:00 2221

Fortis Healthcare recognized for its contribution in positioning India as the Medical Tourism Hub; Conferred with 7 Awards

Fortis was awarded by Advantage Health Care India - an International Summit, which was organized from 26th - 28th April 2023 NEW DELHI, May 23, 2023 /PRNewswire/ -- India's leading hospital chain, Fortis Healthcare has been recognized for its contribution in positioning India as the preferred me...

2023-05-23 20:34 2110

PharmAbcine Receives IND Approval from the Korean MFDS for Phase I Clinical Trial of Its Novel TIE2 Agonistic Antibody in nAMD

DAEJEON, South Korea, May 23, 2023 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the Company received IND (Investigational New Drug) approval from the Korean MFDS (Mi...

2023-05-23 20:00 1522

SK bioscience Presents Solution for Equitable Access of Vaccine at Regionalized Vaccine Manufacturing Collaborative of World Economic Forum

* Jaeyong Ahn, CEO of SK bioscience, presents the 'Glocalization' project to secure the global vaccine accessibility, claiming the importance of international cooperation to establish a regional-based vaccine hub at the Regionalized Vaccine Manufacturing Collaborative Side Event. SEONGNAM, Sout...

2023-05-23 20:00 1807

BrightInsight Named 2023 Global Company of the Year by Frost & Sullivan for Enabling Better Patient Outcomes with Digital Solutions

BrightInsight's Platform and out-of-the-box Disease Management Solution speed time to market for patient apps, enabling biopharma to differentiate their therapies, improve conversion and enhance the patient experience. SAN ANTONIO, May 23, 2023 /PRNewswire/ -- Frost & Sullivan recently analyzed ...

2023-05-23 20:00 2012

Minghui Pharmaceutical Inc. Announces First-in-Human Dose of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody in Phase 1a Healthy Volunteer Study

SHANGHAI and HANGZHOU, China and WILMINGTON, Del., May 23, 2023 /PRNewswire/ -- Minghui Pharmaceutical, Inc., a clinical-stage biopharmaceutical company focusing on oncology and autoimmune diseases, today announced that the phase1a trial of MHB018A has commenced with the dosing of its first subje...

2023-05-23 19:00 4552

Strong first quarter 2023: Sales of Exyte increases by a third year-on year to 2.0 billion euros

* Significant sales increase by 33,6% to €2.0 billion year-on-year * Substantial growth of adjusted EBIT and adjusted EBITDA of around 19% to €113 million and €125 million, respectively * Order intake amounted to €2.4 billion * Positive outlook: Growth strategy "Pathway to Ten" aiming at sa...

2023-05-23 19:00 2143

Introducing Ceretone's Core One: The Revolutionary OTC Hearing Aid Launching on Indiegogo in May

ONTARIO, Calif., May 23, 2023 /PRNewswire/ -- Ceretone, the audiology technology innovator, is excited to announce that its latest product, the Core One, will be launched on Indiegogo onMay 30, 2023. The Core One is set to be the smallest over-the-counter (OTC) hearing aid on the market, providin...

2023-05-23 18:01 1602

Antengene Announces Claudin 18.2 Antibody-Drug Conjugate ATG-022 Granted Orphan Drug Designations by the U.S. FDA for the Treatment of Gastric and Pancreatic Cancers

SHANGHAI and HONG KONG, May 23, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hemato...

2023-05-23 17:25 2370

CPIC: Focusing on the Health Industry and Building a New Ecosystem of "Insurance + Health"

HONG KONG, May 23, 2023 /PRNewswire/ -- As a leading insurance company with a full license and an important participant in the national multi-level social security system, China Pacific Insurance Group (CPIC or the Group) formulated a five-year plan for the development of the health industry as e...

2023-05-23 16:12 1902
1 ... 147148149150151152153 ... 806